Rapid, reliable diagnosis is a necessary condition for the successful treatment of infections. Such diagnostic assays are continually being developed. e paper presents a method for selecting the molecular target for PCR-based diagnostics based on the comparison of RAPD patterns. A sequence encoding Candida glabrata CBS138 hypothetical protein was selected. e limit of detection for PCR and real-time PCR reactions with DNA extracted from blood samples spiked with Candida glabrata was estimated at 1 CFU/ml. e application of the assays developed in this study would thus seem to be promising as a complementary method in the diagnostics of C. glabrata infections.
e number of sequenced genomes and fragments of DNA sequences of pathogenic microorganisms continues to increase. However, some problems still remain as regards the choice of molecular targets for the design of primers for PCR detection and identification.
In this paper, we present a method based on the RAPD technique for the identification of the molecular target for PCR detection applied to Candida glabrata DNA. To date, a number of di erent PCR tests for PCR identification of this pathogen have been published. Some are based on the sequences of lanosterol-alphademethylase and chitin synthase (Burgener-Kairuz et al., 1994; Jordan et al., 1994) . e regions of ribosomal DNA are probably the most o en applied as the molecular targets in PCR diagnostics of pathogenic fungi (Mecler and Nawrot, 2008; Fujita et al., 2001; Chen et al., 2001; Luo et al., 2002) . e golden standard of Candida species identification in reference mycology laboratories is the sequencing of ITS fragments. However, as the NCBI database relies on the work of the authors of the deposited sequences being correct, there are, in fact, a number of incorrectly identified sequences (Ciardo et al., 2006) .
We describe the PCR and real-time PCR assay for the specific detection of the DNA of Candida glabrata.
e primers for the assays were designed on the basis of the C. glabrata sequence identified by comparison of the RAPD patterns which were obtained for di erent Candida species. We selected the identification of C. glabrata as the aim of the PCR-based assays thus developed because this fungus is one of the pathogens a ecting an increasing number of patients (Fidel et al., 1999; Pfaller et al., 2003; Lyon et al., 2010 ). An additional problem related to C. glabrata infections is its resistance to antimycotics (Lyon et al., 2010) . It is estimated that approx. 60% of the C. glabrata strains isolated from ICU patients are resistant to uconazole, which is first line antimycotic applied in hospitals.
e clinical and reference strains used in the presented study for the identification of molecular targets and evaluation of the PCR designed for the specific detection of C. glabrata came from the collection of the Department of Microbiology at the Gdansk University of Technology. e breakdown of the strains is as follows: 37 clinical and 10 reference C. albicans, 30 clinical and 1 reference C. glabrata, 12 clinical and 1 reference C. tropicalis, 9 clinical and 1 reference C. parapsilosis, 2 C. famata, 1 C. dublinensis, 1 C. guillerandalis, 2 C. kefyr, 1 Saccharomyces cerevisiae, 1 C. sake, 3 C. guilleromondi, 3 C. krusei, and 1 C. lusitaniae. e Escherichia coli TOP10F' strain was applied for the cloning of the PCR products selected. e DNA of the microorganisms was purified in line with the Genomic Mini AX Yeast (A&A Biotechnology) protocol. Evaluation of the DNA concentration was performed with the NanoDrop ND-1000 ( ermo Scientific, Germany) New PCR Test for Detection of Candida glabrata Based on the Molecular Target Chosen by the RAPD Technique 1 82 and was placed between 8 and 1161 ng/µl for individual strains. For RAPD purposes, a DNA concentration of up to 30-40 ng/µl was established for all of the samples.
e 50 µl master mixes were prepared directly prior to amplification and consisted of 1 µl (0,5 U/μl) of DNA polymerase Pwo Hypernova (DNA-Gdansk II, Poland), 5 µl of PCR reaction bu er (DNA-Gdansk II, Poland), 5 µl of 20 mM MgCl 2 , 5 µl of 25 mM dNTP's, 2 µl of 10 µM 1247 primer (5' AAGGACCCGT 3'), and 2 µl of 10 µM of 1290 primer (5' GTGGATGCGA 3'). e reaction was performed in the Mastercycler (Eppendorf) and comprised the following stages: 6 min of preliminary denaturation in 94ºC followed by 40 cycles: 1 min -94°C, 1 min -38°C and 1 min -72°C. e final elongation lasted 6 min at 72°C. e RAPD products for particular strains were run by electrophoresis in 6% polyacrylamide gel stained with ethidium bromide and visualized in UV light. Products specific to C. glabrata strains were selected and excised from the 1% agarose gel by means of a Gel-out kit (A&A Biotechnology, Poland). e products were cloned into the pJET1.2 vector in line with the manufacturer's protocol (Fermentas, Lithuania) and used for the transformation of the E. coli TOP10F' strain. Plasmid DNA was extracted (Plasmid Mini, A&A Biotechnology, Poland) from the E. coli colonies cultured for 16 h at 37°C on the Luria Agar in the presence of ampicillin (100 µg/ml).
e inserts from the recombinant plasmids were sequenced by the Genomed (Poland) with the pJET1.2 forward (5' CGACTCACTATAGGGAGAGCGGC 3') and pJET1.2 reverse (5' AAGAACATCGATTTTC-CATGGCAG 3') primers. e sequences obtained were blasted against the NCBI database. e C. glabrata specific PCR was performed in conditions dexribed below. A 0.5 μl of 10 mM solution of each primer was applied with 2.5 μl of PCR reaction bu er (DNA-Gdansk II, Poland), 2.5 µl of 20 mM MgCl 2 , 2.5 µl of 25 mM dNTP's, 0.5 μl of DNA polymerase Pwo Hypernova (DNA-Gdansk II) and 5 μl of the extracted DNA in the 25 μl reaction mixture. e amplification profile consisted of an initial incubation of 3 min at 94°C followed by 40 cycles of 45 s at 94°C, 30 s at 63°C and 45 s at 72°C, with a final 10 min hold at 72°C. e PCR products were separated by agarose gel electrophoresis (2% agarose containing 0.5 μg/ml ethidium bromide in 1 × TBE bu er) and analyses.
e 20 μl of real-time PCR mixture consisted of 0.5 μl of a 10 mM solution of each primer, 10 μl Real Time 2x PCR Mix SYBR B, water and 5 μl of the extracted DNA. e reaction was performed in the LightCycler 1.5 (Roche Applied Science) under the following conditions: pre-incubation: 3 min in 95°C, amplification: 10 sec in 94°C, 10 sec of primers annealing at 63°C and 10 sec of product elongation at 72°C. e reaction was followed by a melting curve analysis
(1 min at 95°C, cooling for 1 min at 65°C, and ramp to 95°C at a ramp rate of 0.1°C/s). In order to estimate the primers' limit of detection from a blood specimen dilution of C. glabrata, 1 ml of EDTA-anticoagulated whole blood sample from a healthy donor was spiked with 30 µl of 24-hour C. glabrata culture. Serial dilutions of the inoculated blood samples were made and the fungal suspensions were concurrently and successively diluted in phosphate bu ered saline. 200 μl of each dilution of saline and the corresponding blood specimen were used for total DNA extraction in line with a modified Genomic Mini AX Yeast (A&A Biotechnology, Poland) protocol: 0.2 ml spheroplast bu er, 50 µl of chitinase and 15 µl 1 M DTT were added to the tubes containing the spiked samples, then mixed and incubated for 30 min at 50°C. e next stages of purification were performed as per the manufacturer's protocol. e precipitated DNA was re-suspended in various volumes of TB bu er. Fungal counts for each dilution in blood and saline were performed in triplicate and enumerated on Sabouraud agar.
e numbers of colony-forming units (10 10 to 10 0 CFU/ml, in serial dilutions) were compared to the presence of 272 bp PCR product, in the case of PCR reaction, and to the presence of the PCR products exhibiting a melting temperature of 86°C in the case of real-time PCR.
e aim of this study was the selection of a molecular target on the basis of a comparison of di erent RAPD patterns appropriate to the designing of primers for PCR identification of Candida glabrata. e selected molecular target should be common for different C. glabrata strains and its specificity should be confirmed within the species which can be found in the specimens under investigation. e RAPD reactions for identification of the C. glabrata specific products representing the specific molecular target were performed with DNA from 3 C. glabrata, 14 C. albicans, 2 C. parapsilosis, 1 C. tropicalis, 1 C. kefyr and 1 C. krusei strains.
e specific PCR product presented only within the RAPD patterns obtained for C. glabrata was selected (Fig. 1.) . Confirmation of the versatility of approximately 1300 bp product's presence was performed by running an RAPD reaction for 9 di erent strains of C. glabrata isolated in di erent geographical areas of Poland, namely, Gdańsk, Szczecin and Warsaw and, additionally, from Sweden. Comparison of the RAPD patterns obtained enabled identification of specific product present only in C. glabrata RAPD profiles to be identified. As the di erent RAPD products can be synthesized on the basis of the same genes, the cloning of the selected product is important. It allows the reading of the whole sequence of the product selected. Such precautions guaranteed that sequence specific primers for the C. glabrata DNA were obtained. e versatile product represented in lanes number: 15, 16, and 17 of Fig. 1 was excised from the agarose gel and cloned into the pJET1.2 vector. e inserted DNA fragment of resulting recombinant plasmid pJETG1 was sequenced. e sequencing results were compared against the NCBI database. e sequence was identified as Candida glabrata CBS138 hypothetical protein. e sequence number CAGL0M05005g was downloaded from the www.candidagenome.org website and a pair of primers, Cgla272FOR (5' GAGTGGTATGACGAG-CAATGGT 3') and Cgla)272REV (5' TTGTATTGAA-GATTCCCTCTCATATATC 3'), was designed.
e theoretical specificity of the primers thus designed, Cgla272FOR and Cgla272REV, was confirmed by blasting their sequences against the NCBI database. e PCR reaction with these primers was performed in an annealing temperature gradient from 50°C to 63°C and an annealing temperature of 63°C was chosen. e versatility of the primers was confirmed, as the specific 272 bp PCR products were detected for all 31 reactions performed with C. glabrata DNA. eir specificity also was confirmed, since no PCR product was detected for the reaction performed with the DNA extracted from 85 di erent non-C. glabrata isolates. e determination of the sensitivity of this PCR reaction was evaluated by running reactions with a row of 10x dilution C. glabrata DNA; the DNA concentration in the samples ranged from 212 ng/µl to 0,000212 ng/µl. e reaction had the capability of detecting approximately 21 pg of DNA.
e same primers were examined for their potential application in real-time PCR with uorophore SYBRGreen. Positive results were obtained for the reactions run with C. glabrata (Cp < 30) and negative results were obtained for non-C. glabrata strains (Cp > 40). e analysis of the melting profile of C. glabrata PCR products was established as ~86°C. In addition, the reaction was performed on human DNA and no product was detected. e determination of the real-time PCR reaction sensitivity was evaluated. e reaction was able to detect 2.12 ng of DNA.
To check the limit of detection of the reactions with these primers, PCR and real-time PCR with DNA extracted from C. glabrata-spiked blood samples were performed. e results of the reactions were compared with the number of C. glabrata colonies corresponding to particular dilutions. e limit of detection for both PCR and real-time PCR detection was established as ~1 CFU, which permits the presumption of their high potential for application in C. glabrata molecular diagnostics. e black arrow indicates the C. glabrata specific PCR product. Lane M: 1000-100 bp DNA marker.
